AstraZeneca

News

With Merck circling, SpringWorks gets new drug approval

Merck KGaA is talking to SpringWorks about a takeover, and FDA approval for a neurofibromatosis drug could have sweetened any potential deal.

News

A still from the Alexion fantasy storybook for children with rare disease aHUS

Storybook can help kids understand rare kidney disease

An e-Book aimed at children with rare kidney disease aHUS can help them understand the condition, deal with emotions, and find support, says Alexion.

News

Pressure relieved on AZ as details of Chinese probe emerge

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

News

Woman in protective clothing in a laboratory

Report says AZ's UK plant decision is not just about funding

It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

News

AstraZeneca abandons plan for £450m vaccine plant in UK

In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.

With Merck circling, SpringWorks gets new drug approval

Storybook can help kids understand rare kidney disease

Pressure relieved on AZ as details of Chinese probe emerge

Report says AZ's UK plant decision is not just about funding

Boost to Enhertu's prospects as FDA clears Roche diagnostic

AstraZeneca abandons plan for £450m vaccine plant in UK

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

AstraZeneca

Editor's Picks